Analytical Method Development for Dual-Chamber Autoinjector

The contract seeks the development and validation of analytical methods to evaluate the stability, purity, and compatibility of HI-6 DMS and atropine sulfate within a dual-chamber autoinjector system, ensuring the integrity and efficacy of the combined formulation under various conditions. The work involves establishing robust, scientifically sound protocols for characterizing chemical and physical properties over time, with attention to potential interactions between the two active ingredients and their compatibility with the autoinjector's materials and design. This effort is critical to support the safe and reliable deployment of the medical countermeasure in operational environments. The solicitation is issued as a subcontract under the North American Industry Classification System code 541380, and is managed by the Department of National Defence on behalf of the Government of Canada. The opportunity was posted on June 2, 2026, with a response deadline of June 16, 2026. Performance is expected to align with Canadian government standards and requirements, though no specific location for performance or set-aside provisions are indicated. Interested parties must submit proposals via the official Canadian government procurement portal prior to the deadline to be considered for award.